Backed by a Bombay High Court order, drug major Sun Pharmaceutical Industries today said it will release salaries of the erstwhile Ranbaxy medical representatives only if they used a company provided software application to report daily activity reports.
A section of ex-Ranbaxy medical representatives (MRs) had challenged in the industrial court in Mumbai Sun Pharma’s move to do away with a software application used by erstwhile Ranbaxy MRs for reporting daily activity reports (DAR) and asked them to switch over to a system provided by it.
The industrial court had granted an interim oder in favour of the MRs. It was challenged by the company in the Bombay High Court.
The court “has granted the company’s request for using the Target Application as the platform for DAR and passed an order in which it has directed the said MRs to start reporting on the Target Application retrospectively”, Sun Pharma said in a BSE filing.
“We have stated very clearly in the court that the company will release the salaries provided these medical representatives (MRs) submit their daily activity reports (DAR) using Target Application,” it added.
As on today the migration of all MRs of the erstwhile Ranbaxy to Target Application has been completed and around 94 per cent of them are reporting on it. The balance 6 per cent are refusing to submit their DAR on Target Application, Sun Pharma said.
As part of the integration of erstwhile Ranbaxy in Sun Pharma it was decided to use Target Application as a single platform for DAR for the India field force, it added.